17/05/2024  17:39:51 Chg. -6.00 Volume Bid17:39:51 Demandez à17:39:51 Capitalisation boursière Dividende Y. Rapport P/E
214.00EUR -2.73% 7,195
Chiffrre d'affaires: 1.55 Mio.
-Bid taille: - -Ask la taille: - 16.47 Mrd.EUR 0.34% 71.24

Description de l'entreprise

The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes.
 

Conseil d'administration & Conseil de surveillance

PDG
Joachim Kreuzburg
Conseil d'administration
Rainer Lehmann, Dr. René Fáber, Gerry MacKay, Alexandra Gatzemeyer
Conseil de surveillance
Dr. Lothar Kappich, Manfred Zaffke, Prof. David Raymond Ebsworth, Dr. Daniela Favoccia, Petra Kirchhoff, Dietmar Müller, Ilke Hildegard Panzer, Frank Riemensperger, Hermann Jens Ritzau, Prof. Dr. Klaus Rüdiger Trützschler, Sabrina Wirth
 

Données de l'entreprise

Nom: Sartorius AG
Adresse: Otto-Brenner-Str. 20,D-37079 Goettingen
Téléphone: +49-551-308-0
Fax: +49-551-308-3289
Courriel: info@sartorius.com
Internet: www.sartorius.de
Industrie: Technology
Secteur: Other Technology Industries
Sous-secteur: -
Fin de l'exercice financier: 31/12
Flotte libre: 40.81%
IPO date: 10/07/1990

Relations avec les investisseurs

Nom: Petra Kirchhoff
Téléphone IR: +49-551-308-1686
IR-Fax: -
E-mail IR: petra.kirchhoff@sartorius.com

Calendrier de l'entreprise

CW 29 | 19/07/2024 Interim Report 2nd Quarter/6 Months
CW 42 | 17/10/2024 Interim Report 3rd Quarter/9 Months
 

Principaux actionnaires

Administered by an executor
 
55.00%
Bio-Rad Laboratories
 
38.00%
Free float
 
7.00%